| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Igc Pharma, Inc. (IGC) has 5 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. IGC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 3.99M | $1.08M | - | |
| Dir | 1.37M | $371.6K | - | |
| Other | 1.13M | $307.4K | - | |
| Dir | 500.0K | $135.5K | - | |
| Dir | 500.0K | $135.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 | Moran James P | Director | Buy | 588,235 | $0.34 | $199,999.90 | +166.1% | +8.3% | +14.5% | |
| Mar 9, 2021 | Prins Richard K | Director | Sell | 50,000 | $1.75 | $87,500.00 | -7.5% | -1.7% | -41.3% | |
| Mar 3, 2021 | Prins Richard K | Director | Sell | 50,000 | $1.80 | $90,005.00 | -3.5% | -19.0% | -42.5% | |
| Mar 2, 2021 | Mukunda Ram | Exec. Chairman &CEO | Sell | 50,000 | $2.14 | $107,000.00 | -1.8% | -25.6% | -46.2% | |
| Dec 1, 2020 | Prins Richard K | Director | Sell | 50,000 | $2.04 | $102,000.00 | -6.3% | - | - | |
| Nov 30, 2020 | Mukunda Ram | Exec. Chairman &CEO | Sell | 80,000 | $2.34 | $187,024.00 | -2.8% | - | - | |
| Aug 30, 2018 | Mukunda Ram | Exec. Chairman &CEO | Sell | 50,000 | $1.87 | $93,260.00 | -2.2% | - | - | |
| Aug 30, 2018 | Grimaldi Claudia | Vice President And Pfo | Sell | 116,020 | $2.00 | $232,040.00 | -17.3% | - | - | |
| Aug 28, 2018 | Mukunda Ram | Exec. Chairman &CEO | Sell | 200,000 | $1.04 | $207,097.50 | -7.0% | - | - | |
| Aug 27, 2018 | Grimaldi Claudia | Vice President And Pfo | Sell | 50,000 | $1.10 | $55,000.00 | -7.8% | - | - |